OBJECTIVE: To assess the benefits of nutrition supplementation in children living with HIV (CLHIV). METHODS: A prospective observational study was carried out at antiretroviral therapy (ART)/pediatric centre of excellence (PCOE), Niloufer hospital for a period of one year in CLHIV (N = 164) aged 1 to 18 y referred to ART/PCOE. Nutrition supplementation was given in the form of Ready to Use Food (About 350 kcal and 12 g of protein per day) supplementation to assess improvement in Height for age Z (HAZ), Weight for Age Z (WAZ), Weight for Height Z (WHZ) and Body Mass Index for age Z (BMIZ) scores over a period of one year. RESULTS: At baseline, 65.5 % and 57.5 % of children below and above 5 y respectively were stunted. 24.1 % and 45.3 % children below and above 5 y respectively were wasted/thin (as assessed by BMI for age). Mean BMIZ score significantly improved in both the age groups (0.96 Z score, P < 0.001) in below and above 5 (0.37 Z score, P < 0.001) respectively at the end of 12 mo. Mean HAZ score also significantly improved in children above 5 y (0.09 Z score, P < 0.05) with non-significant improvement below 5 y (0.14 Z score, P < 0.57) by the end of 12 mo. CONCLUSIONS: Nutrition supplementation over one year resulted in moderate improvement in the nutritional status of CLHIV. However, it is unclear, whether the improvement in nutritional status was due to regular visits to ART centre that may have resulted in better adherence to treatment or an additional benefit of nutrition intervention. This warrants a well-designed randomized controlled trial to examine the benefits of nutrition supplementation in CLHIV attending ART centre.
OBJECTIVE: To assess the benefits of nutrition supplementation in children living with HIV (CLHIV). METHODS: A prospective observational study was carried out at antiretroviral therapy (ART)/pediatric centre of excellence (PCOE), Niloufer hospital for a period of one year in CLHIV (N = 164) aged 1 to 18 y referred to ART/PCOE. Nutrition supplementation was given in the form of Ready to Use Food (About 350 kcal and 12 g of protein per day) supplementation to assess improvement in Height for age Z (HAZ), Weight for Age Z (WAZ), Weight for Height Z (WHZ) and Body Mass Index for age Z (BMIZ) scores over a period of one year. RESULTS: At baseline, 65.5 % and 57.5 % of children below and above 5 y respectively were stunted. 24.1 % and 45.3 % children below and above 5 y respectively were wasted/thin (as assessed by BMI for age). Mean BMIZ score significantly improved in both the age groups (0.96 Z score, P < 0.001) in below and above 5 (0.37 Z score, P < 0.001) respectively at the end of 12 mo. Mean HAZ score also significantly improved in children above 5 y (0.09 Z score, P < 0.05) with non-significant improvement below 5 y (0.14 Z score, P < 0.57) by the end of 12 mo. CONCLUSIONS: Nutrition supplementation over one year resulted in moderate improvement in the nutritional status of CLHIV. However, it is unclear, whether the improvement in nutritional status was due to regular visits to ART centre that may have resulted in better adherence to treatment or an additional benefit of nutrition intervention. This warrants a well-designed randomized controlled trial to examine the benefits of nutrition supplementation in CLHIV attending ART centre.
Entities:
Keywords:
Children living with HIV; Nutrition status; Nutrition supplementation
Authors: Siyazi Mda; Joop M A van Raaij; Una E MacIntyre; François P R de Villiers; Frans J Kok Journal: Matern Child Nutr Date: 2011-04 Impact factor: 3.092
Authors: Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala Journal: JAMA Date: 2006-08-16 Impact factor: 56.272
Authors: Zulfiqar A Bhutta; Tahmeed Ahmed; Robert E Black; Simon Cousens; Kathryn Dewey; Elsa Giugliani; Batool A Haider; Betty Kirkwood; Saul S Morris; H P S Sachdev; Meera Shekar Journal: Lancet Date: 2008-02-02 Impact factor: 79.321
Authors: D C Macallan; C Noble; C Baldwin; S A Jebb; A M Prentice; W A Coward; M B Sawyer; T J McManus; G E Griffin Journal: N Engl J Med Date: 1995-07-13 Impact factor: 91.245
Authors: Bruno F Sunguya; Krishna C Poudel; Linda B Mlunde; Keiko Otsuka; Junko Yasuoka; David P Urassa; Namala P Mkopi; Masamine Jimba Journal: Nutr J Date: 2012-08-29 Impact factor: 3.271